ECG Equipment And Management Systems Market (2022 - 2028)

Report Overview

The global ECG equipment and management systems market size was valued at USD 6.7 billion in 2021 and is expected to expand at a compound annual growth rate (CAGR) of 6.2% from 2022 to 2028. The growing prevalence of cardiac arrhythmia and increasing demand for ambulatory monitoring devices are expected to drive the market. The rising geriatric population, technological advancements, and advancements in ECG equipment and management systems are expected to boost market growth over the forecast period.

The rise in the geriatric population is expected to be a major factor driving the market for ECG equipment and management systems. According to the National Institute on Aging (NIA)-a part of the National Institutes of Health-8.5% of the people worldwide (617 million) is aged 65 or older. In Europe, the population aged 60 years or above was 25.7% in 2017, which is projected to increase to 32.2% by 2050.

The risk of diabetes and cardiovascular diseases increases with age, which results in a higher incidence of these diseases in adults aged 60 and above. According to a study published by American Heart Association in 2016, about 85.6 million adults in the U.S. suffer from one or more cardiovascular diseases, of which, about 43.7 million adults are estimated to be more than 60 years of age.

The shift from paper ECG review to electronic ECG equipment and management systems over the past decade has helped improve efficiency. Moreover, improvement in the ECG equipment and management system such as the development of the open platform has improved integration with Cardiovascular Information Systems (CVIS), smartphones, and cloud-based systems. For instance, in April 2016, GE Healthcare introduced a new version of Muse ECG management system-MUSE v9-that allows clinicians better access to all ECG waveforms and related data from multiple vendors, devices, and test types.

End-use Insights

The hospitals and clinics segment dominated the market for ECG equipment and management systems and accounted for the largest revenue share of more than 43.0% in 2019. This growth is due to the increasing prevalence of cardiac arrhythmias and the rising adoption of Holter devices in hospitals.

The ambulatory facilities segment is expected to witness a CAGR of 6.2% during the forecast period. Technological advancements, shifting interest toward ambulatory centers for treatment, and availability of advanced portable devices like ECG equipment and management systems for ambulatory ECG monitoring are driving the segment growth. As these devices facilitate immediate transfer of data pertaining to outpatient procedures, demand for such devices is increasing in ambulatory centers for accurate assessment of cardiac arrhythmias.

Type Insights

Resting ECG system dominated the type segment with a revenue share of more than 57.0% in 2019. The growth of the segment is characterized by improved clinical accuracy due to new product launches, advanced data analysis tools, and several technological advancements for better care and accurate diagnosis. The ECG management systems segment is expected to grow at the fastest rate over the forecast period.

Regional Insights

North America dominated the ECG equipment and management systems market and accounted for a revenue share of 45.7% in 2019. This is owing to the increasing geriatric population and lifestyle diseases. According to data published by the CDC in June 2020, heart disease accounts for around 647,000 deaths in the U.S. each year. On average, one person dies due to CVD every 37 seconds in the U.S. Furthermore, approval and launch of advanced, next-generation ECG equipment and management systems in the U.S. and Canada and high adoption of wearable devices are likely to boost the growth of the market in the region.

Rising incidence of CVDs, growing geriatric population, and favorable regulatory conditions are expected to boost the growth of the market for ECG equipment and management systems during the forecast period in Europe. In the Asia Pacific, technological advancements, such as wireless and real-time monitoring, increase in healthcare spending, and support from regulatory bodies are anticipated to promote market growth. According to the American Heart Association, among Asians, 6.1% of people have heart diseases, 21.0% have hypertension, 1.9% have had a stroke, and 3.7% have Coronary Heart Disease (CHD). Thus, the presence of a large patient pool, availability of high-quality services, and increasing medical tourism are likely to drive the market for ECG equipment and management systems in the Asia Pacific during the forecast period.

Key Companies & Market Share Insights

The market for ECG equipment and management systems is characterized by the growing prevalence of cardiac arrhythmia and initiatives such as mergers and acquisitions and partnerships by market players. For instance, in 2020, CompuMed extended its partnership with AliveCor and GE Healthcare to expand its product offerings in mobile electrocardiogram (ECG) and ultrasound solutions. The products include AliveCor Heart Monitor, CompuMed powered GE MAC 800, and a pocket-sized visualization tool. Some of the prominent players in the ECG equipment and management systems market include:

• GE Healthcare

• Nihon Kohden Corporation

• BioTelemetry, Inc.

• CompuMed, Inc.

• Schiller AG

• Mindray Medical

• Hill Rom

• Koninklijke Philips N.V.

• Spacelabs Healthcare

• McKesson Corporation

• Drägerwerk AG & Co. KGaA

• Mindray Bio-Medical Electronics Co., Ltd.

• Meditech Equipment Co., Ltd.

• CardioComm Solutions, Inc.

• Device Technologies

• Meditech Equipment Co., Ltd.

• ZOLL Medical Corporation

• Medical ECONET GmbH

ECG Equipment And Management Systems Market